Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort Study

Elkin, Elena B.; Klem, M. L.; Gonzales, Anne Marie; Ishill, Nicole; Hodgson, David C.; Ng, Andrea K.; Marks, Lawrence B.; Weidhaas, Joanne B.; Freedman, Gary M.; Miller, Robert C.; Constine, Louis S.; Myrehaug, Sten; Yahalom, Joachim

doi:10.1200/jco.2010.32.4079

Cited by 92 publications

(80 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies have assessed if BC following HL differs from primary BC in terms of tumor characteristics [16 -19] or prognosis [8,[17][18][19][20][21][22]. In particular, a large population-based study using the dataset from the Surveillance, Epidemiology and End Results (SEER) program reported that, among women with localized BC, patients with previous HL had a twofold greater risk for death resulting from BC than patients without previous HL [18].…”

Section: Introductionmentioning

confidence: 99%

Risk, Characteristics, and Prognosis of Breast Cancer after Hodgkin's Lymphoma

et al. 2012

View full text Add to dashboard Cite

After completing this course, the reader will be able to:1. Explain the differences in risk and aggression of breast cancer for Hodgkin's lymphoma survivors.2. Describe the difference in breast tumor sites for Hodgkin's lymphoma survivors.3. Use adapted guidelines for surveillance and treatment of these high-risk patients.This article is available for continuing medical education credit at CME.TheOncologist.com. CME CME ABSTRACTPurpose. To assess breast cancer (BC) risk after Hodgkin's lymphoma (HL) and compare characteristics, risk of second BC, and prognosis of patients with these BCs with patients with first primary BC.Patients and Methods. We considered all 9,620 women with HL recorded in the Surveillance, Epidemiology and End Results dataset in 1973-2007. We calculated age-period standardized incidence ratios of BC. We compared patient, tumor, and treatment characteristics, risk of second BC, and prognosis between patients with BC after HL (n ‫؍‬ 316) and patients with other BCs occurring during the same period (n ‫؍‬ 450,413) using logistic regression and Cox models adjusted for confounders.Results. HL patients had a 2.

show abstract

Section: Introductionmentioning

confidence: 99%

Risk, Characteristics, and Prognosis of Breast Cancer after Hodgkin's Lymphoma

et al. 2012

View full text Add to dashboard Cite

show abstract

“…In this group, mammography and magnetic resonance imaging complement each other in breast cancer screening. 31 Ng et al reported that, among these patients, the sensitivity of mammography and magnetic resonance imaging, when used separately, is 68% and 67%, respectively. However, when the two methods are used in combination, the sensitivity increases to 94%.…”

Section: Chest Wall Irradiationmentioning

confidence: 99%

Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations

Urban¹,

Chala²,

Bauab³

et al. 2017

Rev. Bras. Mastol. (Impr.)

View full text Add to dashboard Cite

“…8,9 Late effects, especially SPM and cardiovascular events, are well-known after first-line treatment of HL. [10][11][12][13][14][15][16] In contrast, only a few retrospective studies have addressed long-term effects after ASCT for relapsed or refractory HL. 17,18 Thus, long-term prospective data are lacking for first-relapsed or refractory HL treated with ASCT.…”

Section: A B D Cmentioning

confidence: 99%